Investigating Outcomes of Elective Robotic Transhiatal Esophagectomy
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- Northwestern University
- Study ID
- NCT05950438
- Status
- Recruiting
Conditions
- Esophagectomy
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Esophagectomy — PROCEDUREEsophagectomy is a complex surgical procedure performed to treat various esophageal disorders. The surgery involves the removal of all or part of the esophagus and reconstruction using other parts of the gastrointestinal tract.
Study Details
The primary goal of this study is to collect short-term and long-term health outcomes of a robotic transhiatal esophagectomy procedure. Clinical (or health) outcomes measure the effect of the procedure on your overall health status. During this procedure, the surgeon will remove all or part of your esophagus. We want to identify patients who will have this procedure. We will look at data elements before, during, and after your procedure to understand the impact of this surgery on your post-operative clinical outcomes.
Key Dates
- Start date
- Jul 11, 2023
- Status verified
- May 2026
- Primary completion
- May 25, 2028
- Completion
- May 25, 2028
Study Design
- Enrollment
- 120 participants (estimated)
Primary Outcome Measure
Number of Participants with Anastomotic Leak [ Time Frame: During first 3 months postop ]
Central Contacts
- Ankit Bharat, MD312-926-7628
- Sara Krezalek, BSN312-926-7577
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern University | Chicago | Illinois | 60611 |
Find similar trials in Chicago, IL
By research site
Related Studies
- Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of LifeRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Mayo Clinic Upper Digestive Disease SurveyRecruiting · Mayo Clinic · Rochester, Minnesota
- Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)Recruiting · Universitaire Ziekenhuizen KU Leuven · Houston, Texas
- Stellate Ganglion BlockPHASE4 · Recruiting · University of Minnesota · Minneapolis, Minnesota